Rani Therapeutics Holdings(RANI)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RANI Rani Therapeutics Holdings

未开盘 01-12 16:00:00 EST

1.49

+0.09

+6.43%

盘后1.50

+0.01+0.67%

19:56 EST

最高1.54	最低1.37	成交量256.81万
今开1.42	昨收1.40	日振幅11.95%
总市值1.81亿	流通市值9,967万	总股本1.22亿
成交额377.07万	换手率3.84%	流通股本6,689万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"RANI","market":"US","secType":"STK","nameCN":"Rani Therapeutics Holdings","latestPrice":1.49,"timestamp":1768251600000,"preClose":1.4,"halted":0,"volume":2568122,"hourTrading":{"tag":"盘后","latestPrice":1.5,"preClose":1.49,"latestTime":"19:56 EST","volume":24008,"amount":35889.426,"timestamp":1768265789208},"delay":0,"floatShares":66891000,"shares":121511580,"eps":-0.758815,"marketStatus":"未开盘","change":0.09,"latestTime":"01-12 16:00:00 EST","open":1.42,"high":1.54,"low":1.3727,"amount":3770726.535967,"amplitude":0.1195,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.758815,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1768294800000},"marketStatusCode":0,"adr":0,"listingDate":1627617600000,"exchange":"NASDAQ","adjPreClose":1.4,"preHourTrading":{"tag":"盘前","latestPrice":1.42,"preClose":1.4,"latestTime":"09:29 EST","volume":26016,"amount":37108.660454,"timestamp":1768228170021},"postHourTrading":{"tag":"盘后","latestPrice":1.5,"preClose":1.49,"latestTime":"19:56 EST","volume":24008,"amount":35889.426,"timestamp":1768265789208},"volumeRatio":2.044427,"impliedVol":1.2797,"impliedVolPercentile":0.504},"requestUrl":"/m/hq/s/RANI","defaultTab":"news","newsList":[{"id":"1157511377","title":"Rani Therapeutics携手Progen启动Rt-114 Ranipill®治疗肥胖症的I期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1157511377","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1157511377?lang=zh_cn&edition=full","pubTime":"2026-01-08 20:00","pubTimestamp":1767873613,"startTime":"0","endTime":"0","summary":"Rani Therapeutics Holdings宣布，已与Progen公司合作正式启动Rt-114 Ranipill®用于肥胖症治疗的I期临床研究。该试验旨在评估这款口服制剂的安全性、耐受性及初步疗效，为后续开发奠定基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","RANI","BK4539"],"gpt_icon":0},{"id":"1136817636","title":"Rani Therapeutics Holdings与中外制药公司达成10.85亿美元合作，开发多项高价值治疗药物","url":"https://stock-news.laohu8.com/highlight/detail?id=1136817636","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1136817636?lang=zh_cn&edition=full","pubTime":"2025-11-07 05:33","pubTimestamp":1762464789,"startTime":"0","endTime":"0","summary":"Rani Therapeutics Holdings与中外制药公司达成10.85亿美元合作，开发多项高价值治疗药物","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RANI","BK4539","BK4007"],"gpt_icon":0},{"id":"1168378948","title":"Rani Therapeutics任命Abe Bassan和Vasudev Bailey, Ph.d.为董事会成员","url":"https://stock-news.laohu8.com/highlight/detail?id=1168378948","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1168378948?lang=zh_cn&edition=full","pubTime":"2025-10-24 04:06","pubTimestamp":1761249976,"startTime":"0","endTime":"0","summary":"Rani Therapeutics任命Abe Bassan和Vasudev Bailey, Ph.d.为董事会成员","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4007","RANI"],"gpt_icon":0},{"id":"1167938917","title":"Rani Therapeutics完成超额认购的6030万美元私募融资，遵循纳斯达克市场定价规则","url":"https://stock-news.laohu8.com/highlight/detail?id=1167938917","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1167938917?lang=zh_cn&edition=full","pubTime":"2025-10-24 04:02","pubTimestamp":1761249751,"startTime":"0","endTime":"0","summary":"Rani Therapeutics完成超额认购的6030万美元私募融资，遵循纳斯达克市场定价规则","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"655cd07df3f4ca0af6725c95ad371c7d","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4007","RANI"],"gpt_icon":0},{"id":"1172742365","title":"Rani Therapeutics Holdings高管 Martin Abraham Guiloff Salvador 卖出总计5923000股","url":"https://stock-news.laohu8.com/highlight/detail?id=1172742365","media":"老虎公告助手","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1172742365?lang=zh_cn&edition=full","pubTime":"2025-10-23 07:00","pubTimestamp":1761174013,"startTime":"0","endTime":"0","summary":"Rani Therapeutics Holdings的董事 Martin Abraham Guiloff Salvador 于2025年10月20日和10月21日分别减持了1,923,000股和4,000,000股普通股。交易完成后，总持股量为2,379,194股。密集减持可能表明对公司未来走势的担忧，投资者应关注市场反应。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Rani Therapeutics Holdings高管 Martin Abraham Guiloff Salvador 卖出总计5923000股","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RANI"],"gpt_icon":0},{"id":"1196560915","title":"中外制药有限公司 - 签署口服制剂开发与商业化的许可协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1196560915","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1196560915?lang=zh_cn&edition=full","pubTime":"2025-10-20 07:32","pubTimestamp":1760916727,"startTime":"0","endTime":"0","summary":"中外制药有限公司 - 签署口服制剂开发与商业化的许可协议","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","RANI","BK4539"],"gpt_icon":0},{"id":"2576052600","title":"美股异动 | 与中外制药达成10.85亿美元合作协议 Rani Therapeutics(RANI.US)飙升超265%","url":"https://stock-news.laohu8.com/highlight/detail?id=2576052600","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576052600?lang=zh_cn&edition=full","pubTime":"2025-10-17 23:40","pubTimestamp":1760715611,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周五，Rani Therapeutics(RANI.US)飙升超265%，盘中一度熔断，股价创年内新高，报1.76美元。消息面上，该公司宣布与中外制药Chugai达成高达10.85亿美元的合作协议，获得1000万美元预付款，并有资格获得最高7500万美元技术转让与发展里程碑金、1亿美元销售里程碑金及个位数特许权使用费，同时中外制药有权选择扩展至5个额外药物靶点。Rani Therapeutics主营生物制品口服递送技术，核心平台RaniPill®专注于口服抗体及罕见病药物开发，此次合作应用于中外制药的罕见病抗体项目，验证技术应用价值。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1356687.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1191","BK4139","01477","BK4007","RANI","BK4539","LENZ"],"gpt_icon":0},{"id":"2576709881","title":"Maia Biotechnology, Inc.盘中异动 早盘股价大跌5.19%报1.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2576709881","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576709881?lang=zh_cn&edition=full","pubTime":"2025-10-17 23:12","pubTimestamp":1760713945,"startTime":"0","endTime":"0","summary":"北京时间2025年10月17日23时12分，Maia Biotechnology, Inc.股票出现波动，股价急速跳水5.19%。Maia Biotechnology, Inc.股票所在的生物技术行业中，整体跌幅为0.47%。其相关个股中，Rani Therapeutics Holdings, Inc.、Artiva Biotherapeutics, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大，Xortx Therapeutics Inc.、Rani Therapeutics Holdings, Inc.、Artiva Biotherapeutics, Inc.较为活跃，换手率分别为1514.46%、479.85%、227.49%，振幅较大的相关个股有Rani Therapeutics Holdings, Inc.、Apollomics Inc C/Wts 01/04/2028 、Nls Pharmaceutics Ltd C/Wts 02/02/2026，振幅分别为148.65%、79.83%、61.69%。Maia Biotechnology, Inc.公司简介：MAIA Biotechnology Inc 是一家临床阶段的生物制药公司，致力于开发针对癌症的靶向免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101723122594cf5cd6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101723122594cf5cd6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","MAIA","BK4007","RANI"],"gpt_icon":0},{"id":"2576886096","title":"Os Therapies Incorporated盘中异动 快速下跌5.14%报1.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2576886096","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576886096?lang=zh_cn&edition=full","pubTime":"2025-10-17 22:13","pubTimestamp":1760710391,"startTime":"0","endTime":"0","summary":"北京时间2025年10月17日22时13分，Os Therapies Incorporated股票出现波动，股价急速下挫5.14%。截至发稿，该股报1.76美元/股，成交量33.3201万股，换手率0.99%，振幅6.91%。Os Therapies Incorporated股票所在的生物技术行业中，整体涨幅为0.05%。Os Therapies Incorporated公司简介：OS Therapies Inc 是一家临床阶段的生物制药公司，专注于骨肉瘤和其他实体肿瘤治疗的鉴定、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251017221312a4654783&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251017221312a4654783&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","RANI","BK4539","ARTV","BK4097","OS","OSTX"],"gpt_icon":0},{"id":"1125763316","title":"Rani Therapeutics Holdings股价在与日本中外制药达成高达10.9亿美元的许可交易后几乎上涨三倍","url":"https://stock-news.laohu8.com/highlight/detail?id=1125763316","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1125763316?lang=zh_cn&edition=full","pubTime":"2025-10-17 21:36","pubTimestamp":1760708172,"startTime":"0","endTime":"0","summary":"Rani Therapeutics Holdings股价在与日本中外制药达成高达10.9亿美元的许可交易后几乎上涨三倍。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","RANI","BK4539"],"gpt_icon":0},{"id":"2576101306","title":"Absci Corporation盘中异动 早盘大幅下跌5.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2576101306","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576101306?lang=zh_cn&edition=full","pubTime":"2025-10-17 21:34","pubTimestamp":1760708046,"startTime":"0","endTime":"0","summary":"北京时间2025年10月17日21时34分，Absci Corporation股票出现异动，股价急速下挫5.85%。截至发稿，该股报4.59美元/股，成交量57.4068万股，换手率0.38%，振幅3.29%。Absci Corporation股票所在的生物技术行业中，整体跌幅为0.28%。其相关个股中，Rani Therapeutics Holdings, Inc.、Artiva Biotherapeutics, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大，Xortx Therapeutics Inc.、Rani Therapeutics Holdings, Inc.、Artiva Biotherapeutics, Inc.较为活跃，换手率分别为1021.57%、259.44%、129.63%，振幅较大的相关个股有Rani Therapeutics Holdings, Inc.、Adaptimmune Therapeutics Plc、冠科美博，振幅分别为33.98%、20.95%、18.76%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251017213407a6bef5eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251017213407a6bef5eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABSI","BK4139","BK4539","BK4007","RANI","ARTV","BK4121"],"gpt_icon":0},{"id":"1136773283","title":"Rani Therapeutics 股价在盘前交易中翻倍，因与日本中外制药达成高达10.9亿美元的许可协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1136773283","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1136773283?lang=zh_cn&edition=full","pubTime":"2025-10-17 19:51","pubTimestamp":1760701871,"startTime":"0","endTime":"0","summary":"Rani Therapeutics 股价在盘前交易中翻倍，因与日本中外制药达成高达10.9亿美元的许可协议。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4007","RANI"],"gpt_icon":0},{"id":"1197151594","title":"Rani Therapeutics Holdings : 中外制药可选择扩展与公司在最多5个额外药物靶点的合作权利","url":"https://stock-news.laohu8.com/highlight/detail?id=1197151594","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1197151594?lang=zh_cn&edition=full","pubTime":"2025-10-17 19:32","pubTimestamp":1760700739,"startTime":"0","endTime":"0","summary":"Rani Therapeutics Holdings : 中外制药可选择扩展与公司在最多5个额外药物靶点的合作权利","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4539","RANI"],"gpt_icon":0},{"id":"1102360548","title":"Rani Therapeutics与中外制药达成高达10.85亿美元合作协议，涉及多种高价值治疗领域，包括罕见病和免疫学项目，并宣布同时进行6030万美元的超额融资","url":"https://stock-news.laohu8.com/highlight/detail?id=1102360548","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1102360548?lang=zh_cn&edition=full","pubTime":"2025-10-17 19:32","pubTimestamp":1760700731,"startTime":"0","endTime":"0","summary":"Rani Therapeutics与中外制药达成高达10.85亿美元的合作协议，涵盖多个高价值治疗领域，包括罕见疾病和免疫学项目。与此同时，Rani Therapeutics还宣布进行了6030万美元的超额融资。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","RANI","BK4539"],"gpt_icon":0},{"id":"1148817856","title":"Rani Therapeutics宣布超额认购的6030万美元私募配售，按纳斯达克规则定价","url":"https://stock-news.laohu8.com/highlight/detail?id=1148817856","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1148817856?lang=zh_cn&edition=full","pubTime":"2025-10-17 19:32","pubTimestamp":1760700730,"startTime":"0","endTime":"0","summary":"Rani Therapeutics宣布超额认购6030万美元的私募配售，按纳斯达克规则进行市场定价。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","RANI","BK4539"],"gpt_icon":0},{"id":"2551846191","title":"Abvc Biopharma, Inc.盘中异动 早盘快速下挫5.54%报3.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551846191","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551846191?lang=zh_cn&edition=full","pubTime":"2025-07-14 21:34","pubTimestamp":1752500090,"startTime":"0","endTime":"0","summary":"北京时间2025年07月14日21时34分，Abvc Biopharma, Inc.股票出现异动，股价急速下跌5.54%。Abvc Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.19%。其相关个股中，Dare Bioscience, Inc.、Biomx Inc.、Rani Therapeutics Holdings, Inc.涨幅较大，Windtree Therapeutics, Inc.、Dare Bioscience, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为1622.55%、360.91%、170.99%，振幅较大的相关个股有Dare Bioscience, Inc.、Biomx Inc.、Rani Therapeutics Holdings, Inc.，振幅分别为70.78%、44.41%、21.09%。Abvc Biopharma, Inc.公司简介：ABVC BioPharma Inc 是一家临床阶段生物制药公司，目前正在开发六种药物和一种医疗器械。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071421345097a5bd4a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071421345097a5bd4a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","RANI","ABVC","BK4139","BK4539"],"gpt_icon":0},{"id":"2551872351","title":"Salarius Pharmaceuticals, Inc.盘中异动 急速跳水5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551872351","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551872351?lang=zh_cn&edition=full","pubTime":"2025-07-14 21:34","pubTimestamp":1752500042,"startTime":"0","endTime":"0","summary":"北京时间2025年07月14日21时34分，Salarius Pharmaceuticals, Inc.股票出现异动，股价大幅下挫5.08%。Salarius Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.19%。其相关个股中，Dare Bioscience, Inc.、Biomx Inc.、Rani Therapeutics Holdings, Inc.涨幅较大，Windtree Therapeutics, Inc.、Dare Bioscience, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为1620.74%、344.95%、170.85%，振幅较大的相关个股有Dare Bioscience, Inc.、Biomx Inc.、Rani Therapeutics Holdings, Inc.，振幅分别为59.24%、44.41%、21.09%。Salarius Pharmaceuticals, Inc.公司简介：Salarius Pharmaceuticals Inc 是一家临床阶段的生物制药公司，专注于开发针对具有高医疗需求的癌症的有效治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714213402a6a8f11e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714213402a6a8f11e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SLRX","BK4539","RANI","BK4007","BK4139"],"gpt_icon":0},{"id":"2518150278","title":"Rani Therapeutics Holdings, Inc.盘中异动 早盘快速下挫5.13%报1.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518150278","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518150278?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:22","pubTimestamp":1741616561,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时22分，Rani Therapeutics Holdings, Inc.股票出现波动，股价大幅下跌5.13%。Rani Therapeutics Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.47%。Rani Therapeutics Holdings, Inc.公司简介：Rani Therapeutics Holdings Inc 是一家临床阶段生物治疗公司，其先进的技术使得开发口服生物制剂技术，为患者，医生和医疗保健系统提供方便的注射剂以外的另一种选择成为可能。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310222241a26a386f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310222241a26a386f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","RANI","BK4139","BK4539"],"gpt_icon":0},{"id":"2517392371","title":"Rani Therapeutics Holdings, Inc.盘中异动 快速拉升5.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517392371","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517392371?lang=zh_cn&edition=full","pubTime":"2025-03-06 03:17","pubTimestamp":1741202267,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日03时17分，Rani Therapeutics Holdings, Inc.股票出现异动，股价急速上涨5.59%。Rani Therapeutics Holdings, Inc.股票所在的生物技术行业中，整体涨幅为2.18%。Rani Therapeutics Holdings, Inc.公司简介：Rani Therapeutics Holdings Inc 是一家临床阶段生物治疗公司，其先进的技术使得开发口服生物制剂技术，为患者，医生和医疗保健系统提供方便的注射剂以外的另一种选择成为可能。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306031747a2611713&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306031747a2611713&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RANI","LENZ","BK4007","BK4139","BK4539"],"gpt_icon":0},{"id":"2516658032","title":"Rani Therapeutics Holdings, Inc.盘中异动 急速下跌5.12%报1.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516658032","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516658032?lang=zh_cn&edition=full","pubTime":"2025-03-03 23:58","pubTimestamp":1741017488,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日23时58分，Rani Therapeutics Holdings, Inc.股票出现异动，股价大幅下跌5.12%。Rani Therapeutics Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.48%。Rani Therapeutics Holdings, Inc.公司简介：Rani Therapeutics Holdings Inc 是一家临床阶段生物治疗公司，其先进的技术使得开发口服生物制剂技术，为患者，医生和医疗保健系统提供方便的注射剂以外的另一种选择成为可能。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303235809a25d5b6b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303235809a25d5b6b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4539","BK4007","RANI","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ranitherapeutics.com","stockEarnings":[{"period":"1week","weight":0.0956},{"period":"1month","weight":0.1119},{"period":"3month","weight":2.076},{"period":"6month","weight":2.6341},{"period":"1year","weight":0.192},{"period":"ytd","weight":0.1037}],"compareEarnings":[{"period":"1week","weight":0.0108},{"period":"1month","weight":0.0197},{"period":"3month","weight":0.0497},{"period":"6month","weight":0.1136},{"period":"1year","weight":0.1975},{"period":"ytd","weight":0.0194}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Rani Therapeutics Holdings, Inc.于2021年4月6日在特拉华州注册成立。该公司是一家临床阶段的生物治疗公司，推进技术以促进口服生物制剂的开发，该公司认为这有可能改变医学并改善患者的治疗效果。该公司开发了 RaniPill 胶囊，这是该公司新颖的、专有的和专利的平台技术，旨在用口服给药代替皮下或静脉注射生物制剂。","yearOnYearQuotes":[{"month":1,"riseRate":0.8,"avgChangeRate":0.071774},{"month":2,"riseRate":0.75,"avgChangeRate":0.033575},{"month":3,"riseRate":0,"avgChangeRate":-0.179251},{"month":4,"riseRate":0.25,"avgChangeRate":0.187294},{"month":5,"riseRate":0,"avgChangeRate":-0.208482},{"month":6,"riseRate":0.25,"avgChangeRate":-0.118539},{"month":7,"riseRate":0.75,"avgChangeRate":-0.021139},{"month":8,"riseRate":0.4,"avgChangeRate":0.087585},{"month":9,"riseRate":0.2,"avgChangeRate":-0.146008},{"month":10,"riseRate":0.6,"avgChangeRate":0.658105},{"month":11,"riseRate":0.6,"avgChangeRate":0.053129},{"month":12,"riseRate":0.2,"avgChangeRate":-0.107417}],"exchange":"NASDAQ","name":"Rani Therapeutics Holdings","nameEN":"Rani Therapeutics Holdings"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Rani Therapeutics Holdings(RANI)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Rani Therapeutics Holdings(RANI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Rani Therapeutics Holdings,RANI,Rani Therapeutics Holdings股票,Rani Therapeutics Holdings股票老虎,Rani Therapeutics Holdings股票老虎国际,Rani Therapeutics Holdings行情,Rani Therapeutics Holdings股票行情,Rani Therapeutics Holdings股价,Rani Therapeutics Holdings股市,Rani Therapeutics Holdings股票价格,Rani Therapeutics Holdings股票交易,Rani Therapeutics Holdings股票购买,Rani Therapeutics Holdings股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Rani Therapeutics Holdings(RANI)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Rani Therapeutics Holdings(RANI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}